BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25885213)

  • 1. Luminal B subtype: a key factor for the worse prognosis of young breast cancer patients in China.
    Tang LC; Jin X; Yang HY; He M; Chang H; Shao ZM; Di GH
    BMC Cancer; 2015 Mar; 15():201. PubMed ID: 25885213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].
    Zhang HM; Zhang BN; Xuan LX; Zhao P
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathological characteristics and prognosis of different molecular types of breast cancer].
    Liu ZF; Chen C; Yao XL; Sun SR
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1733-7. PubMed ID: 27356638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different prognosis of young breast cancer patients in their 20s and 30s depending on subtype: a nationwide study from the Korean Breast Cancer Society.
    Ryu JM; Yu J; Kim SI; Kim KS; Moon HG; Choi JE; Jeong J; Do Byun K; Nam SJ; Lee JE; Lee SK; Kim SW
    Breast Cancer Res Treat; 2017 Dec; 166(3):833-842. PubMed ID: 28831642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical features and prognosis analysis of different breast cancer molecular subtypes].
    Yang Q; Chen J; Li HJ; Yu M; Tian CX; Lü Q
    Zhonghua Zhong Liu Za Zhi; 2011 Jan; 33(1):42-6. PubMed ID: 21575463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical characteristics and prognosis of different subtypes of breast cancer].
    Yuan ZY; Wang SS; Zhu MQ; Zheng L; Luo WB; Zhou ZM; Guan ZZ
    Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):456-61. PubMed ID: 19024523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Characteristics and Prognosis of Pregnancy-Associated Breast Cancer: Poor Survival of Luminal B Subtype.
    Bae SY; Jung SP; Jung ES; Park SM; Lee SK; Yu JH; Lee JE; Kim SW; Nam SJ
    Oncology; 2018; 95(3):163-169. PubMed ID: 29913459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast-conserving therapy for triple-negative breast cancer.
    Gangi A; Chung A; Mirocha J; Liou DZ; Leong T; Giuliano AE
    JAMA Surg; 2014 Mar; 149(3):252-8. PubMed ID: 24382582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes.
    Cancello G; Maisonneuve P; Rotmensz N; Viale G; Mastropasqua MG; Pruneri G; Montagna E; Dellapasqua S; Iorfida M; Cardillo A; Veronesi P; Luini A; Intra M; Gentilini O; Scarano E; Goldhirsch A; Colleoni M
    Breast Cancer Res Treat; 2011 Jun; 127(3):713-20. PubMed ID: 21452022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple negative breast cancer in Korea-distinct biology with different impact of prognostic factors on survival.
    Lee JA; Kim KI; Bae JW; Jung YH; An H; Lee ES;
    Breast Cancer Res Treat; 2010 Aug; 123(1):177-87. PubMed ID: 20574671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
    Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
    BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Retrospective Survival Analysis of Anatomic and Prognostic Stage Group Based on the American Joint Committee on Cancer 8th Edition Cancer Staging Manual in Luminal B Human Epidermal Growth Factor Receptor 2-negative Breast Cancer.
    Xu L; Li JH; Ye JM; Duan XN; Cheng YJ; Xin L; Liu Q; Zhou B; Liu YH
    Chin Med J (Engl); 2017 Aug; 130(16):1945-1952. PubMed ID: 28776547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Subtypes and Prognosis in Young Mexican Women With Breast Cancer.
    Villarreal-Garza C; Mohar A; Bargallo-Rocha JE; Lasa-Gonsebatt F; Reynoso-Noverón N; Matus-Santos J; Cabrera P; Arce-Salinas C; Lara-Medina F; Alvarado-Miranda A; Ramírez-Ugalde MT; Soto-Perez-de-Celis E
    Clin Breast Cancer; 2017 Jun; 17(3):e95-e102. PubMed ID: 28065398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Clinicopathological Factors Associated with Disease Progression in Luminal A Breast Cancer and Characteristics of Metastasis: A Retrospective Study from A Single Center in China.
    Ye J; Wang W; Xin L; Owen S; Xu L; Duan X; Cheng Y; Zhang H; Zhang S; Li T; Liu Y
    Anticancer Res; 2017 Aug; 37(8):4549-4556. PubMed ID: 28739751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer in young women: have the prognostic implications of breast cancer subtypes changed over time?
    Sheridan W; Scott T; Caroline S; Yvonne Z; Vanessa B; David V; Karen G; Stephen C
    Breast Cancer Res Treat; 2014 Oct; 147(3):617-29. PubMed ID: 25209005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database.
    Chen HL; Zhou MQ; Tian W; Meng KX; He HF
    PLoS One; 2016; 11(10):e0165409. PubMed ID: 27798652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort study.
    Hennigs A; Riedel F; Gondos A; Sinn P; Schirmacher P; Marmé F; Jäger D; Kauczor HU; Stieber A; Lindel K; Debus J; Golatta M; Schütz F; Sohn C; Heil J; Schneeweiss A
    BMC Cancer; 2016 Sep; 16(1):734. PubMed ID: 27634735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of small T1a/b breast cancer by tumor subtype.
    Ignatov T; Eggemann H; Burger E; Costa SD; Ignatov A
    Breast Cancer Res Treat; 2017 May; 163(1):111-118. PubMed ID: 28233107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone receptor loss identifies luminal-type local advanced breast cancer with poor survival in patients who fail to achieve a pathological complete response to neoadjuvant chemotherapy.
    Chen S; Huang L; Chen CM; Shao ZM
    Oncotarget; 2015 Jul; 6(20):18174-82. PubMed ID: 26053183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective study of breast cancer subtypes: the risk of relapse and the relations with treatments.
    Wang Y; Yin Q; Yu Q; Zhang J; Liu Z; Wang S; Lv S; Niu Y
    Breast Cancer Res Treat; 2011 Nov; 130(2):489-98. PubMed ID: 21837481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.